Merve Gürler, Mustafa Kürsat Gōkcan, Seher Yüksel, Zeynep Ceren Karahan
{"title":"Association between human herpesviruses and head and neck squamous cell carcinoma: a molecular perspective.","authors":"Merve Gürler, Mustafa Kürsat Gōkcan, Seher Yüksel, Zeynep Ceren Karahan","doi":"10.5144/0256-4947.2025.104","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Head and neck cancer (HNC) is the seventh most common malignant tumor. Herpesviruses are a significant risk factor in the multifactorial pathogenesis of HNC.</p><p><strong>Objectives: </strong>This study aimed to investigate the association between herpesviruses and the development of head and neck squamous cell carcinoma (HN-SCC).</p><p><strong>Design: </strong>Experimental study.</p><p><strong>Setting: </strong>A university hospital in Turkey.</p><p><strong>Patients and methods: </strong>Pathological archive tissue samples of 500 patients were included in the study. These samples were categorized into two groups: those diagnosed with HN-SCC (n=300, malignant group [MG]) and those diagnosed with benign head and neck lesions (n=200, benign group [BG]). The presence of herpesvirus in samples was detected using polymerase chain reaction.</p><p><strong>Main outcome measures: </strong>Association of herpesviruses in the development of head and neck cancer.</p><p><strong>Sample size: </strong>500 patients.</p><p><strong>Results: </strong>HHV-1, -2, -7, and -8 were not detected in any samples. In the malignant group (MG), EBV-DNA was detected in 1 patient (0.3%) and HHV-6 DNA in 2 patients (0.6%), while in the benign group (BG), VZV-DNA was detected in 1 patient (0.5%), EBV-DNA in 3 patients (1.5%), CMV-DNA in 5 patients (2.5%), and HHV-6 DNA in 3 patients (1.5%). While no significant difference was found between the groups for VZV, EBV, and HHV-6, a statistically significant difference was found in favor of the benign group for CMV.</p><p><strong>Conclusion: </strong>Although herpesvirus seroprevalence is relatively high in the population, the lack of viral genome in tissue samples indicates that other factors might be prominent in developing HN-SCC.</p><p><strong>Limitation: </strong>The storage conditions of the sample used (paraffinized sample) may have negatively affected the detection frequency of HHVs.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"45 2","pages":"104-111"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11973434/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Saudi medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5144/0256-4947.2025.104","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/3 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Head and neck cancer (HNC) is the seventh most common malignant tumor. Herpesviruses are a significant risk factor in the multifactorial pathogenesis of HNC.
Objectives: This study aimed to investigate the association between herpesviruses and the development of head and neck squamous cell carcinoma (HN-SCC).
Design: Experimental study.
Setting: A university hospital in Turkey.
Patients and methods: Pathological archive tissue samples of 500 patients were included in the study. These samples were categorized into two groups: those diagnosed with HN-SCC (n=300, malignant group [MG]) and those diagnosed with benign head and neck lesions (n=200, benign group [BG]). The presence of herpesvirus in samples was detected using polymerase chain reaction.
Main outcome measures: Association of herpesviruses in the development of head and neck cancer.
Sample size: 500 patients.
Results: HHV-1, -2, -7, and -8 were not detected in any samples. In the malignant group (MG), EBV-DNA was detected in 1 patient (0.3%) and HHV-6 DNA in 2 patients (0.6%), while in the benign group (BG), VZV-DNA was detected in 1 patient (0.5%), EBV-DNA in 3 patients (1.5%), CMV-DNA in 5 patients (2.5%), and HHV-6 DNA in 3 patients (1.5%). While no significant difference was found between the groups for VZV, EBV, and HHV-6, a statistically significant difference was found in favor of the benign group for CMV.
Conclusion: Although herpesvirus seroprevalence is relatively high in the population, the lack of viral genome in tissue samples indicates that other factors might be prominent in developing HN-SCC.
Limitation: The storage conditions of the sample used (paraffinized sample) may have negatively affected the detection frequency of HHVs.
背景:头颈癌(HNC)是第七大常见恶性肿瘤。疱疹病毒是HNC多因素发病机制中的一个重要危险因素。目的:本研究旨在探讨疱疹病毒与头颈部鳞状细胞癌(HN-SCC)发展的关系。设计:实验研究。环境:土耳其的一所大学医院。患者和方法:纳入500例患者的病理档案组织样本。将这些样本分为两组:诊断为HN-SCC的患者(n=300,恶性组[MG])和诊断为头颈部良性病变的患者(n=200,良性组[BG])。用聚合酶链反应检测样品中疱疹病毒的存在。主要结局指标:疱疹病毒与头颈癌发展的关系。样本量:500例患者。结果:所有样品均未检出HHV-1、-2、-7和-8。恶性组(MG)中检出EBV-DNA 1例(0.3%),HHV-6 DNA 2例(0.6%),良性组(BG)中检出VZV-DNA 1例(0.5%),EBV-DNA 3例(1.5%),CMV-DNA 5例(2.5%),HHV-6 DNA 3例(1.5%)。虽然VZV, EBV和HHV-6组之间无显著差异,但CMV良性组的差异有统计学意义。结论:尽管人群中疱疹病毒的血清阳性率相对较高,但组织样本中缺乏病毒基因组表明,其他因素可能在HN-SCC的发生中起重要作用。限制:所用样品(石蜡样)的储存条件可能对hhv的检测频率产生负面影响。